Navamedic ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Navamedic ASA announces FY 2014 financial guidance
Navamedic ASA:Expects continued sales growth in H2 2014, both organically and through the addition of new products.
Latest Key Developments in Pharmaceuticals
- Sawai Pharmaceutical Co Ltd updates on business acquisition from subsidiary of Mitsubishi Tanabe Pharma
- Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd receives investigation notice
- Shanghai Shenqi Pharmaceutical Investment Management Co Ltd signs equity cooperation memorandum
- Tasly Pharmaceutical Group Co Ltd updates private placement
- Share this
- Digg this